Market News

Biohaven Surges After Pricing of Public Offering

Shares of Biohaven (NYSE: BHVN) surged in morning trading on Friday after the clinical-stage biopharmaceutical company announced the pricing of the public offering of 25 million of its common stock, at a price of $10.50 per share. 

Biohaven has granted the underwriters of the public offering a 30-day option to purchase up to an additional 3.75 million common shares. The offering is expected to close on October 25 and the company intends to use the net proceeds for general corporate purposes.

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More